Delivery Order SPE2DB22D3004-SPE2DB24FNS22
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,988.40 order is for the supply of emtricitabine-tenofovir 200-300 milligram tablets, a pharmaceutical product, with a performance period through April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA, which...
- This is a $5,490.77 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of emtricitabine-tenofovir 200-300mg tablets, a medication used to treat HIV. The contract has an ultimate completion date of March 27, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The $12,657.86 delivery order contract is for the supply of emtricitabine-tenofovir 200-300 mg tablets, which are used to treat HIV/AIDS. The contract has a ceiling value of $12,657.86 and runs through August 24, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,098.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of emtricitabine-tenofovir 200-300mg tablets, a specialty medication used to treat HIV. The award was made under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,162.41 contract is for the delivery of Emtricitabine-Tenofovir 200-300mg prescription medication, a common treatment for HIV. The contract has an ultimate completion date of April 24, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award is for the delivery of emtricitabine-tenofovir 200-300 mg tablets, a pharmaceutical product used to treat HIV. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $3,523.63 and a completion date of March 10, 2022. It was awarded on March 9, 2022, and was not set aside for any specific business...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,752.24 firm fixed-price contract is for the supply of emtricitabine-tenofv 200-300mg tablets for a term ending on November 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,116.81 firm fixed-price delivery order contract is for the supply of emtricitabine-tenofovir 200-300mg prescription medication. The award has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $1,785.13 to AmerisourceBergen Drug Corp for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units. The contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $10,388.81 to AmerisourceBergen Drug Corp for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of October 23, 2025, issued one day after the award date of October 22, 2025. The contract was competitively awarded without any set-aside designation and will be performed at the awardee's corporate office location in Conshohocken,...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FNS22Delivery Order
This is a $1,241.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of emtricitabine-tenofovir 200-300 mg tablets, a medication commonly used in the treatment of HIV. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/13/23 |